Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
Authors:
- 20 March 2009
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 39 (5) , 407-414
Abstract
(2009). Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Xenobiotica: Vol. 39, No. 5, pp. 407-414.Keywords
This publication has 29 references indexed in Scilit:
- Limited Sampling Strategy for Simultaneous Estimation of the Area Under the Concentration-Time Curve of Tacrolimus and Mycophenolic Acid in Adult Renal Transplant RecipientsTherapeutic Drug Monitoring, 2008
- Carboxylesterase in the liver and small intestine of experimental animals and humanLife Sciences, 2007
- Influence of UGT1A7 and UGT1A9 Intronic I399 Genetic Polymorphisms on Mycophenolic Acid Pharmacokinetics in Japanese Renal Transplant RecipientsTherapeutic Drug Monitoring, 2007
- Circadian Pharmacokinetics of Mycophenolic Acid and Implication of Genetic Polymorphisms for Early Clinical Events in Renal Transplant RecipientsTransplantation, 2006
- Pharmacokinetics and Bioavailability of Mycophenolic Acid After Intravenous Administration and Oral Administration of Mycophenolate Mofetil to Heart Transplant RecipientsTherapeutic Drug Monitoring, 2005
- IDENTIFICATION OF THE UDP-GLUCURONOSYLTRANSFERASE ISOFORMS INVOLVED IN MYCOPHENOLIC ACID PHASE II METABOLISMDrug Metabolism and Disposition, 2005
- Pharmacogenomic assessment of carboxylesterases 1 and 2Genomics, 2004
- PRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1998
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Purification and characterization of a human liver arylacetamide deacetylaseBiochemical and Biophysical Research Communications, 1991